NIDCR's Summer 2021 E-Newsletter

Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities &Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR to Release Report on Oral Health in America As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions in the prevention and treatment of oral disease, identify disparities and inequalities in oral health care, and propose innovative strategies for ensuring the public shares equally in the benefits of oral health. Details about key findings and highlighted data can be found on a forthcoming website and related publications. IADR/AADR/CADR Virtual Annual Meeting NIDCR leadership, program staff, investigators, and trainees will be joining the virtual 2021 IADR/AADR/CADR General Session from July 21 to 24, including pre-meeting activities July 15 and 16. Attendees are welcome to visit NIDCR’s virtual booth to get information about research and training programs and to sign up for one-on-one consultations with NIDCR program officers. To learn more about NIDCR-sponsored symposia and other events, access the schedule on NIDCR’s ...
Source: NIDCR Science News - Category: Dentistry Source Type: news

Related Links:

During her career, Debbie DiCarlo had worked for nonprofits dealing with immigration, foster case, sex trafficking and domestic violence, but she never saw herself working for a cancer organization. That is, until her best friend was diagnosed with cancer, and she subsequently moved to the Valley from California to do just that.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
One new case in Queensland as Melbourne CBD turned into no-go zone and police prepare to disrupt protest planned in SydneyNew Doherty modelling advises ‘medium’ Covid restrictions until 80% vaccination target reachedYouth corrections officer dies from CovidCovid vaccine rollout and rates tracker; Cases, trends and data trackerGet our free news app;get our morning email briefing2.05amBSTNSW isn ’t hosting a press conference today.Instead NSW Health ’sJeremy McAnulty is providing an update via NSW Health ’s Facebook page. You can watchhere.2.02amBSTNSW has recorded 1,331 new locally acquired cas...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Australia news Infectious diseases Science Medical research Source Type: news
During her career, Debbie DiCarlo had worked for nonprofits dealing with immigration, foster case, sex trafficking and domestic violence, but she never saw herself working for a cancer organization. That is, until her best friend was diagnosed with cancer, and she subsequently moved to the Valley from California to do just that.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news
Source: Oral Radiology - Category: Radiology Source Type: research
Mississippi health officials have issued an advisory that COVID-19 vaccines are safe, effective and recommended to pregnant women after reports some were turned away at clinics.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra doses for those who are 65 or older or run a high risk of severe disease
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Shares of a Bay Area biotech company shot up more than 157% and another climbed to a lesser degree Friday after a Big Pharma company reported that a cancer drug with a shared target appeared effective in fighting tumors. Both Corvus Pharmaceuticals Inc. (Nasdaq: CRVS) of Burlingame and Arcus Biosciences Inc. (NYSE: RCUS) of Hayward shot up after AstraZeneca plc reported fresh data from a mid-stage clinical trial. That Big Pharma player said its already-approved cancer immunotherapy Imfinzi showed…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
Health authorities in Louisiana say a child is among the latest to die from COVID-19 in Louisiana
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news
Advisory committee endorses third dose only for elderly and at-risk groups in blow to Biden
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Research published this week indicated the booster shots were not now necessary for everyone, a view that prevailed at the agency ’s advisory committee meeting.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Coronavirus (2019-nCoV) Vaccination and Immunization Disease Rates Science and Technology Research Source Type: news
More News: Academia | AIDS Vaccine | American Health | Arthritis | Autoimmune Disease | Biochemistry | Biology | Brain | Brain Cancers | Budgets | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Child Development | Childhood Cancer | Clinical Trials | Coronavirus | COVID-19 | Dentistry | Education | Emergency Medicine | Funding | Gene Therapy | Genetics | Geriatrics | Grants | Harvard | Head and Neck Cancer | Health Management | Heart | Heart Transplant | HIV AIDS | Induction of Labor | International Medicine & Public Health | Learning | Lung Transplant | Lupus | Medical Ethics | Men | Molecular Biology | Neurology | Neuroscience | Neurosurgery | Nicotine | Oral Cancer | Outbreaks | Oxford University | Pandemics | Partnerships | Politics | Rare Diseases | Rheumatoid Arthritis | Rheumatology | SARS | Science | Skin | Skin Graft | Small Businesses | Stem Cell Therapy | Stem Cells | Study | Training | Transplant Surgery | Transplants | Universities & Medical Training | University of Pennsylvania | Vaccines | Websites | Wikis